Steroid treatment for suspected acute myocarditis in hospital
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether steroid medicine helps people hospitalized with suspected acute myocarditis (inflammation of the heart). Participants are randomly assigned to receive steroids or a placebo, and the trial looks at outcomes after the acute episode starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re admitted to the hospital for suspected acute myocarditis (acute heart inflammation).
- You’re age 18 to 69, and symptoms started within the last 3 weeks.
- Blood tests suggest heart strain and injury (high NT-proBNP or BNP, plus troponin that’s at least 3 times the normal upper limit).
- Your echocardiogram shows reduced heart pumping (LVEF under 41%) and certain heart size measurements (LV-EDD under 56 mm).
- You’re randomized within 120 hours (5 days) of being admitted, and coronary artery disease has been ruled out if you’re 46 or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests abatacept to treat myocarditis (inflammation of the heart muscle) caused by immune checkpoint cancer medicines. It may help patients recover faster and safely manage this serious side effect while they are in the hospital.
This trial tests whether giving steroids, immunoglobulins, or both can help people with a sudden, severe heart muscle inflammation (myocarditis) that causes shock or dangerous heart rhythms. The goal is to see if these treatments improve recovery compared to standard care.
This trial tests if non-steroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, help people with acute myocarditis (inflammation of the heart muscle) who are hospitalized but have normal heart function. It aims to see if these drugs can reduce inflammation and improve recovery.
This study follows people who have been hospitalized for a sudden inflammation of the heart muscle (myocarditis) to understand their risk of developing irregular heartbeats (arrhythmias). It aims to identify who might need closer monitoring or extra treatment to prevent complications.
This study looks back at people who were hospitalized for myocarditis (inflammation of the heart muscle) to see if a special measurement of blood flow in the tiny heart vessels can predict how well they do over the next year. The findings might help doctors better understand and treat this condition.
This study is creating a national registry to learn more about inflammatory myocardial disease (inflammation of the heart muscle). If you have symptoms like chest pain, shortness of breath, palpitations, or certain test results, you may be eligible to join and help advance research.
Hear when a new Myocarditis Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.